BioMed Research International

BioMed Research International / 2016 / Article

Research Article | Open Access

Volume 2016 |Article ID 8076989 | 7 pages |

Influenza Virus Induces Inflammatory Response in Mouse Primary Cortical Neurons with Limited Viral Replication

Academic Editor: Muhammad Mukhtar
Received23 Feb 2016
Accepted02 Jun 2016
Published21 Jul 2016


Unlike stereotypical neurotropic viruses, influenza A viruses have been detected in the brain tissues of human and animal models. To investigate the interaction between neurons and influenza A viruses, mouse cortical neurons were isolated, infected with human H1N1 influenza virus, and then examined for the production of various inflammatory molecules involved in immune response. We found that replication of the influenza virus in neurons was limited, although early viral transcription was not affected. Virus-induced neuron viability decreased at 6 h postinfection (p.i.) but increased at 24 h p.i. depending upon the viral strain. Virus-induced apoptosis and cytopathy in primary cortical neurons were not apparent at 24 h p.i. The mRNA levels of inflammatory cytokines, chemokines, and type I interferons were upregulated at 6 h and 24 h p.i. These results indicate that the influenza virus induces inflammatory response in mouse primary cortical neurons with limited viral replication. The cytokines released in viral infection-induced neuroinflammation might play critical roles in influenza encephalopathy, rather than in viral replication-induced cytopathy.

1. Background

Influenza virus is an enveloped, multiple-segmented, negative-stranded RNA virus that mainly infects the respiratory tract and causes health problems ranging from common cold-like symptoms to severe infections such as pneumonia. Influenza virus is also associated with many neurological complications such as encephalopathy/encephalitis syndrome, Reye’s syndrome, hemorrhagic shock, encephalopathy syndrome, and acute necrotizing encephalopathy [13].

The microenvironment of central nervous system (CNS) is highly specialized and is considered an immune-privileged site due to the CNS-driven passive interactions with the immune system [4, 5]. These mechanisms involve neuron and glial cells including microglia, astrocytes, and oligodendrocytes [5]. Microglia belong to resident phagocytic cells which function as the first line of CNS defense, and astrocytes are the principal source of cytokines secretion upon stress, injury, and infection. Microgliosis and astrocytosis play roles in a spectrum of neurodegenerative disorders [6, 7]. Neurons have traditionally been implicated as the sole targets of microglia cytotoxicity and innocent victims of overactivated immune cells. Recent researches, however, have demonstrated that neurons might host and regulate innate and adaptive immune responses to counter viral infection in the CNS [810].

Accumulating evidences have shown that the RNA and antigen of the neurovirulent influenza virus can be detected in the neurons of human, mice, and birds [1113]. Influenza virus enters CNS and induces neuroinflammation and neurodegeneration [7]. Previous studies demonstrated that both human H1N1 and avian H5N1 influenza viruses infect microglia, astrocytes, and neuronal cell lines in vitro, inducing production of proinflammatory cytokines and ultimately leading to cell apoptosis or cytopathy [1416].

The present study was to determine the potential role of neurons in the innate immune response to the influenza virus. We examined cytokine expression, viral susceptibility and production, cell viability, and apoptosis in the infected neurons. We found that neurons upregulated the expression of cytokines, chemokines, and type I interferons (IFNs) to counter influenza infection. In addition, the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling was not activated in neurons after influenza virus infection.

2. Materials and Methods

2.1. Animals

This study was preapproved by the Ethical Committee of Shantou University Medical College. Specific pathogen-free C57 BL/6 18-day-old pregnant mice were purchased from Shantou University Medical College Laboratory Animal Center (Shantou, Guangdong, China).

2.2. Cell Culture

C57 BL/6 female mice were mated with male mice, and vaginal plugs were checked every morning. Embryonic day (E0.5) refers to the day that a vaginal plug was found. To collect embryos, the pregnant females were euthanized and E17.5 embryos were dissected from the uteri. Cortical neurons from the embryos were isolated as previously described [17]. Briefly, cortices were dissociated in phosphate-buffered saline (PBS, 0.01 M, pH 7.4) and plated (1 × 106 cells/mL) on poly-D-lysine- (PDL-) coated plates. The neurons were grown in plating medium containing Dulbecco’s Modified Eagle’s Medium with 10% fetal bovine serum and antibiotics (100 units/mL penicillin, 100 μg/mL streptomycin, and 0.25 μg/mL amphotericin B; Gibco BRL). Plating medium was changed into neurobasal medium with 2% B27 supplemented and 0.5 mM Glutamax and antibiotics after 6 h. About one-half of the culture medium was replaced every 3-4 days. The cultures were maintained at 37°C in a 5% CO2 humidified atmosphere.

2.3. Viruses and Viral Titers

Two influenza virus H1N1 strains, A/PR/8/34 (PR8) and A/Shantou/169/2006 (ST169), were used in this study. The titers of PR8 and ST169 were diluted into 2 × 106 PFU (plaque forming units)/mL. Viral titers were determined by plaque assay on Madin-Darby canine kidney (MDCK) as previously described [14]. Briefly, 90% of confluent MDCK cell monolayers were infected with 10-fold dilutions of influenza virus in a total volume of 1 mL Minimum Essential Medium (MEM)/0.2% BSA for 1 h in a 6-well plate. After washing, cells were covered with an overlay of MEM cell culture medium containing 0.9% low melting point agarose. Cells were incubated at 37°C under 5% CO2 and plaque formation was analyzed 3 days postinfection (p.i.).

2.4. Cell Infections

The neurons were washed twice with PBS and infected with viruses at a multiplicity of infection (MOI) of 2. One hour postinfection, cells were washed once with PBS and cultured with fresh neuron culture medium. Untreated control cells were included in each independent experiment as negative controls. The cell culture supernatants of infected neurons were collected at 0, 6, and 24 h p.i., and their cell suspensions were collected at 0, 6, and 24 h p.i. and stored at −80°C until subsequent use.

2.5. Real-Time PCR

Total RNA was extracted from virus infected and control samples using Trizol reagent (Invitrogen, USA) according to the manufacturer’s instructions. First-strand cDNA synthesis was performed with the M-MLV enzyme (Invitrogen, USA) in a final volume of 20 μL. The samples were diluted with DEPC (diethylpyrocarbonate) water to a 1 : 25-fold concentration. Real-time PCR was performed using the 7300 Fast Real-Time PCR system (ABI, USA). Quantification of the target genes was performed with 2x platinum quantitative PCR supermix-UDG kit (Invitrogen, USA) and specific primer sets (Qiagen, Germany) according to the manufacturer’s instructions. The specificity of the SYBR Green PCR signal was confirmed by melting curve analysis. In each experiment, mouse β-actin mRNA was amplified as a control. Each threshold cycle (Ct) value was calculated by taking an average of the values obtained from triplicate samples. To examine virus infection and neuronal viral growth kinetics, viral mRNA, viral RNA (vRNA), and complementary (cRNA) levels in infected neurons were detected by real-time PCR at 6 h and 24 h p.i., respectively.

2.6. Enzyme Linked Immunosorbent Assay of IL-6 and TNF-α

Production of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in the supernatants of mouse primary neurons was determined using specific enzyme linked immunosorbent assay (ELISA) kits (Dakewe, China) according to the manufacturer’s instructions. The culture supernatants of the infected and uninfected control cells were irradiated with UVP CX-2000 Crosslinker (UVP, Upland, CA, USA) for 15 min to make virus ineffective before subjecting to ELISA. No infective virus particles were detected by plaque assay after ultraviolet (UV) irradiation. The dose of UV light used did not affect cytokine concentration, as confirmed by our previous experiments.

2.7. Cell Viability and Apoptosis Assay

Cell viability was assessed with a cell counting kit-8 (Dojindo Laboratories, Kumamoto, Japan). Cells were seeded and grown for 5 days in 96-well plates at a density of 1 × 105 cells per well in neural culture medium prior to any treatment. After treating with influenza A virus (MOI = 2), 10 μL of kit reagent was added and the solution was incubated for another 2 h. Cell viability was determined by scanning with a microplate reader at 450 nm. The results were expressed relative to the control values specified in each experiment and were subjected to statistical analysis. A quantitative enzymatic activity assay was performed according to the instructions of the caspase-3 activity assay kit (Roche Applied Science, Mannheim, Germany). Absorbance was measured at 505 nm.

2.8. Immunofluorescence Staining

For immunofluorescence staining, cells were fixed in 4% paraformaldehyde and penetrated with 0.2% Triton X-100 and 0.04% SDS in PBS. The cells were incubated with 1 : 500 diluted rabbit anti-mouse beta-tubulin III antibody (Santa Cruz, CA, USA) for neuron identification or 1 : 1000 diluted rabbit anti-mouse NF-κB p65 antibody (Cell Signaling, Danvers, MA, USA) for NF-κB location. Later, the cells were incubated with fluorescence-labeled secondary antibody (Beyotime, Haimen, China) and 1 μg/mL Hoechst 33258. The processed cells were imaged by fluorescence microscopy.

2.9. Hemagglutination Assay

The culture supernatants of infected neurons were gradient diluted 1 : 2 in PBS (0.01 M, pH 7.4) in a serial 2-fold dilution. The diluted supernatants (50 μL/well) were mixed with the equal volumes of 1% guinea pig red blood cells in V-shaped 96-well microtiter plates to determine virus hemagglutinin (HA) titers.

2.10. Statistical Analysis

Student’s -test was used to compare the difference between virus infected and uninfected cells. The data were presented as mean ± SD. The differences were considered statistically significant at . The statistical analysis was done using the SPSS 13.0 for Windows (Chicago, IL, USA).

3. Results

3.1. Infection of Primary Neurons by Human Influenza Viruses

The cultured cells showed a typical neuronal morphology (Figure 1(a)). Hoechst 33258- and β-tubulin III immunostain displayed that the purity of primary mouse cortical neurons was over 95% (Figure 1(b)).

Primary mouse neurons were infected with two strains of H1N1 (PR8 and A/Shantou/169/06) viruses. The expression of viral matrix mRNA was detectable in the neurons at 6 h p.i. and increased at 24 h p.i. In contrast, the expression of vRNA and cRNA in neurons was decreased postinfection (Figure 2). HA titers of the supernatants from infected neurons at 6 and 24 h p.i. were determined. Undetected HA titer confirmed that influenza virus progeny was absent or very low in the supernatants.

Immunostaining of NF-κB showed that NF-κB located in cytosol in uninfected neurons and did not translocate into nuclei after virus infection (Figure 3).

3.2. Induction of Cytokines following Infection

To analyze the response of cytokines in infected neurons, the gene expression of proinflammatory cytokines, chemokines, antivirus cytokines, and anti-inflammatory cytokines was analyzed by real-time PCR at 6 and 24 h p.i. The results showed that the expression of IL-6, TNF-α, CXCL-10, IFN-β, IL-10, and TGF-β was increased significantly after PR8 and ST169 infection (Figure 4). Interestingly, ST169 upregulated proinflammatory cytokine TNF-α expression more sharply than PR8. Moreover, the level of anti-inflammatory cytokine expression (IL-10 and TGF-β) increased dramatically after PR8 infection but increased moderately after ST169 infection. It might suggest that the severity of neuroinflammation depends upon the viral strain.

3.3. Viability of Neurons after Influenza Virus Infection

To determine the effects of influenza virus on neuron viability, cell counting kit-8 assay was conducted. As shown in Figure 5, the viability of neurons dropped to 44.5% and 41% at 6 h p.i. upon infection of PR8 and ST169, respectively. Neuronal cell recovery could be detected in PR8 inflected neurons at 24 h p.i. (cell viability rose from 44.5% to 84.1%), whereas moderate recovery of cell viability could be observed in ST169 inflected neurons.

Viral infection-induced cytopathic effects were not observed. Consistently, we also found the level of caspase-3 in infected neurons did not alter significantly, comparing to the uninfected controls (data not shown). Both cytopathy and apoptosis of neuron were not induced directly by influenza virus infection.

4. Discussion

Some variant strains of human influenza virus (WSN33 and pH1N1) and avian influenza (H5 and H7 subtypes) have been shown to possess neurotropic tendency [18]. The potential routes for influenza A virus spreading into CNS are hematogenous spread or neural spread, which is related to the subtype of influenza A virus [19, 20]. Although influenza RNA was not always detected, neurovirulent influenza viruses are still considered to play an important role in neurodegenerative disease or encephalitis [7, 21, 22].

Our present work also showed that influenza virus (low pathogenic H1N1) infected cortical neurons in vitro without significant increase of new progeny virus, which was consistent with previous studies [15]. However, by examining influenza A virus genomic RNA and cRNA expression levels, we found that their levels did not significantly change at 6 h to 24 h p.i., indicating that viral genomic RNA replication was efficiently inhibited in the neuron. It is well known that NF-κB signaling pathway is required for efficient influenza A virus replication and the differential regulation of influenza virus RNA synthesis [23]. Therefore, absence of NF-κB activation in our work might contribute to the lack of influenza virus replication. In addition, innate immune pathways are the first defense response for the immediate control and eventual clearance of pathogens, which may also play a role in efficiently inhibiting influenza virus replication.

Apoptosis is an important defense mechanism against intracellular pathogen infection (especially viral infection) through curb pathogen replication and dissemination. Virus-induced neuronal apoptosis has been demonstrated in vitro and in vivo by animal experiments previously [24]. However, in the present work, virus-induced apoptosis was not apparent, suggesting that influenza virus causes neuron injury by indirect immunopathogenesis instead of direct viral damage.

Cytokines play a dual role in CNS virus infection. Whereas moderate innate mediators mediate a protected response which leads to viral clearance and tissue recovery, however, uncontrolled production of proinflammatory cytokines could result in immunopathogenesis [25]. It is well known that influenza virus infection can induce a cascade of cytokines including proinflammatory and anti-inflammatory cytokines, chemokines, and antivirus cytokines [26]. Our previous study also showed that the proinflammatory cytokines IL-6 and TNF-α were upregulated in microglia and astrocytes at the mRNA and protein levels in the early phase (6 h) as well as in the late phase (24 h) after H1N1 infection in vitro [13]. The present study showed that IL-6 and TNF-α were also upregulated at the mRNA level after H1N1 exposure, in accordance with previous studies. Chemokine CXCL10, as a signaling mediator, can activate microglia and direct them to the lesions and is constitutively expressed by neurons [27]. Our results showed that CXCL10 mRNA expression levels were significantly upregulated at 6 h and 24 h p.i., suggesting that it might contribute to the neuropathogenesis after viral infection. INFs are hallmarks of the antivirus response and are critical in the host defense to viruses by modulating the innate and adaptive immune response. Our study showed that IFN-β mRNA levels were upregulated at 24 h p.i., suggesting neurons’ antivirus effect was activated, since neurons could take an active part in the anti-influenza defense by being both IFN-β producers and responders [28]. As the important mediators of negative regulation, anti-inflammatory cytokines such as IL-10 and TGF-β play important roles in maintaining the balance between protective immunity and the development of immune pathology in the context of infectious disease [29]. IL-10 and TGF-β mRNA levels increased at 24 h p.i. because neuraminidase of most influenza A viruses can convert latent TGF-β to active TGF-β, which plays a pivotal role in protecting the host from influenza pathogenesis [30]. Our results demonstrated that neurons might protect themselves by upregulating IL-10 and TGF-β.

Generally, the interactions between virus strains and cells are complex and the specific antivirus immune response is both virus- and cell-dependent. Influenza virus enters CNS and infects and activates the glial cells, which may subsequently induce neuron injury by causing neuroinflammation and neurodegeneration. In this study, we demonstrate that influenza virus replication was limited in purified cultures of neurons and direct virus-induced neuron apoptosis was not apparent. However, the cytokines were upregulated by viral infection, which might induce microgliosis and astrocytosis. The cytokines released in viral infection-induced neuroinflammation may play key roles in influenza encephalopathy, rather than in viral replication-induced cytopathy.

Competing Interests

The authors declare that they have no competing interests.


This study was supported by the grants from National Natural Science Foundation of China (31300761, 81001322, and 31170852) and the Foundation for Distinguished Young Teachers in Higher Education of Guangdong (Yq2013077), as well as the Department of Education, Guangdong Government, under the Top-Tier University Development Scheme for Research and Control of Infectious Diseases.


  1. M. Mizuguchi, “Influenza encephalopathy and related neuropsychiatric syndromes,” Influenza and other Respiratory Viruses, vol. 7, no. 3, pp. 67–71, 2013. View at: Publisher Site | Google Scholar
  2. J. J. Ekstrand, “Neurologic complications of influenza,” Seminars in Pediatric Neurology, vol. 19, no. 3, pp. 96–100, 2012. View at: Publisher Site | Google Scholar
  3. G. F. Wang, W. Li, and K. Li, “Acute encephalopathy and encephalitis caused by influenza virus infection,” Current Opinion in Neurology, vol. 23, no. 3, pp. 305–311, 2010. View at: Publisher Site | Google Scholar
  4. A. Chavarría and G. Cárdenas, “Neuronal influence behind the central nervous system regulation of the immune cells,” Frontiers in Integrative Neuroscience, vol. 7, 2013. View at: Publisher Site | Google Scholar
  5. M. J. Carson, J. M. Doose, B. Melchior, C. D. Schmid, and C. C. Ploix, “CNS immune privilege: hiding in plain sight,” Immunological Reviews, vol. 213, no. 1, pp. 48–65, 2006. View at: Publisher Site | Google Scholar
  6. M. Batlle, L. Ferri, C. Andrade et al., “Astroglia-microglia cross talk during neurodegeneration in the rat hippocampus,” BioMed Research International, vol. 2015, Article ID 102419, 15 pages, 2015. View at: Publisher Site | Google Scholar
  7. H. Jang, D. Boltz, K. Sturm-Ramirez et al., “Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 33, pp. 14063–14068, 2009. View at: Publisher Site | Google Scholar
  8. H. Cho, S. C. Proll, K. J. Szretter, M. G. Katze, M. Gale, and M. S. Diamond, “Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses,” Nature Medicine, vol. 19, no. 4, pp. 458–464, 2013. View at: Publisher Site | Google Scholar
  9. K. Biber, H. Neumann, K. Inoue, and H. W. G. M. Boddeke, “Neuronal ‘On’ and ‘Off’ signals control microglia,” Trends in Neurosciences, vol. 30, no. 11, pp. 596–602, 2007. View at: Publisher Site | Google Scholar
  10. S. Chakraborty, A. Nazmi, K. Dutta, and A. Basu, “Neurons under viral attack: victims or warriors?” Neurochemistry International, vol. 56, no. 6-7, pp. 727–735, 2010. View at: Publisher Site | Google Scholar
  11. J. Gu, Z. Xie, Z. Gao et al., “H5N1 infection of the respiratory tract and beyond: a molecular pathology study,” The Lancet, vol. 370, no. 9593, pp. 1137–1145, 2007. View at: Publisher Site | Google Scholar
  12. Z. Zhang, J. Zhang, K. Huang et al., “Systemic infection of avian influenza A virus H5N1 subtype in humans,” Human Pathology, vol. 40, no. 5, pp. 735–739, 2009. View at: Publisher Site | Google Scholar
  13. W. Zou, J. Ke, A. Zhang et al., “Proteomics analysis of differential expression of chicken brain tissue proteins in response to the neurovirulent H5N1 avian influenza virus infection,” Journal of Proteome Research, vol. 9, no. 8, pp. 3789–3798, 2010. View at: Publisher Site | Google Scholar
  14. G. Wang, J. Zhang, W. Li et al., “Apoptosis and proinflammatory cytokine responses of primary mouse microglia and astrocytes induced by human H1N1 and avian H5N1 influenza viruses,” Cellular & Molecular Immunology, vol. 5, no. 2, pp. 113–120, 2008. View at: Publisher Site | Google Scholar
  15. Y. P. Ng, S. M. Y. Lee, T. K. W. Cheung, J. M. Nicholls, J. S. M. Peiris, and N. Y. Ip, “Avian influenza H5N1 virus induces cytopathy and proinflammatory cytokine responses in human astrocytic and neuronal cell lines,” Neuroscience, vol. 168, no. 3, pp. 613–623, 2010. View at: Publisher Site | Google Scholar
  16. K. Pringproa, R. Rungsiwiwut, R. Tantilertcharoen et al., “Tropism and induction of cytokines in human embryonic-stem cells-derived neural progenitors upon inoculation with highly-pathogenic avian H5N1 influenza virus,” PLoS ONE, vol. 10, no. 8, Article ID e0135850, 2015. View at: Publisher Site | Google Scholar
  17. T. J. Kingsbury, P. D. Murray, L. L. Bambrick, and B. K. Krueger, “Ca2+-dependent regulation of TrkB expression in neurons,” The Journal of Biological Chemistry, vol. 278, no. 42, pp. 40744–40748, 2003. View at: Publisher Site | Google Scholar
  18. K. Shinya, A. Suto, M. Kawakami et al., “Neurovirulence of H7N7 influenza a virus: brain stem encephalitis accompanied with aspiration pneumonia in mice. Brief Report,” Archives of Virology, vol. 150, no. 8, pp. 1653–1660, 2005. View at: Publisher Site | Google Scholar
  19. D. van Riel, R. Verdijk, and T. Kuiken, “The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system,” The Journal of Pathology, vol. 235, no. 2, pp. 277–287, 2015. View at: Publisher Site | Google Scholar
  20. E. J. A. Schrauwen, S. Herfst, L. M. Leijten et al., “The multibasic cleavage site in H5N1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets,” Journal of Virology, vol. 86, no. 7, pp. 3975–3984, 2012. View at: Publisher Site | Google Scholar
  21. T. Iwasaki, S. Itamura, H. Nishimura et al., “Productive infection in the murine central nervous system with avian influenza virus A (H5N1) after intranasal inoculation,” Acta Neuropathologica, vol. 108, no. 6, pp. 485–492, 2004. View at: Publisher Site | Google Scholar
  22. S. Fujimoto, M. Kobayashi, O. Uemura et al., “PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis,” The Lancet, vol. 352, no. 9131, pp. 873–875, 1998. View at: Publisher Site | Google Scholar
  23. E. Haasbach, S. J. Reiling, C. Ehrhardt et al., “The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus,” Antiviral Research, vol. 99, no. 3, pp. 336–344, 2013. View at: Publisher Site | Google Scholar
  24. I. Mori, T. Komatsu, K. Takeuchi, K. Nakakuki, M. Sudo, and Y. Kimura, “In vivo induction of apoptosis by influenza virus,” The Journal of General Virology, vol. 76, no. 11, pp. 2869–2873, 1995. View at: Publisher Site | Google Scholar
  25. G. Ramesh, A. G. Maclean, and M. T. Philipp, “Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain,” Mediators of Inflammation, vol. 2013, Article ID 480739, 20 pages, 2013. View at: Publisher Site | Google Scholar
  26. J. R. Teijaro, “The role of cytokine responses during influenza virus pathogenesis and potential therapeutic options,” Current Topics in Microbiology and Immunology, vol. 386, pp. 3–22, 2015. View at: Publisher Site | Google Scholar
  27. J. Vinet, E. K. de Jong, H. W. G. M. Boddeke et al., “Expression of CXCL10 in cultured cortical neurons,” Journal of Neurochemistry, vol. 112, no. 3, pp. 703–714, 2010. View at: Publisher Site | Google Scholar
  28. S. Delhaye, S. Paul, G. Blakqori et al., “Neurons produce type I interferon during viral encephalitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 20, pp. 7835–7840, 2006. View at: Publisher Site | Google Scholar
  29. V. Swarup, J. Ghosh, R. Duseja, S. Ghosh, and A. Basu, “Japanese encephalitis virus infection decrease endogenous IL-10 production: correlation with microglial activation and neuronal death,” Neuroscience Letters, vol. 420, no. 2, pp. 144–149, 2007. View at: Publisher Site | Google Scholar
  30. C. M. Carlson, E. A. Turpin, L. A. Moser et al., “Transforming growth factor-β: activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis,” PLoS Pathogens, vol. 6, no. 10, Article ID e1001136, 2010. View at: Publisher Site | Google Scholar

Copyright © 2016 Gefei Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

1388 Views | 424 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.